Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Sarepta Therapeutics Company Profile (NASDAQ:SRPT)

Consensus Ratings for Sarepta Therapeutics (NASDAQ:SRPT) (?)
Ratings Breakdown: 1 Sell Rating(s), 7 Hold Rating(s), 13 Buy Rating(s)
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: $38.86 (64.93% upside)

Analysts' Ratings History for Sarepta Therapeutics (NASDAQ:SRPT)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/13/2014ZacksReiterated RatingNeutral -> Neutral$20.00ViewTweet This Rating  Share This Rating on StockTwits
10/7/2014Credit SuisseReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
9/24/2014Credit SuisseInitiated CoverageOutperform$36.00ViewTweet This Rating  Share This Rating on StockTwits
8/19/2014Cowen and CompanyInitiated CoverageOutperform$44.00ViewTweet This Rating  Share This Rating on StockTwits
7/31/2014OppenheimerInitiated CoverageOutperform$45.00ViewTweet This Rating  Share This Rating on StockTwits
7/30/2014Deutsche BankReiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
7/29/2014WBB SecuritiesUpgradeSpeculative Buy -> BuyViewTweet This Rating  Share This Rating on StockTwits
7/29/2014WBB SecuritiesBoost Price TargetSpeculative Buy -> Buy$25.00ViewTweet This Rating  Share This Rating on StockTwits
7/22/2014Bank of AmericaInitiated CoverageNeutral$27.00ViewTweet This Rating  Share This Rating on StockTwits
5/22/2014Roth CapitalInitiated CoverageBuy$52.00ViewTweet This Rating  Share This Rating on StockTwits
4/22/2014Deutsche BankBoost Price TargetPositive -> Hold$17.00 -> $35.00ViewTweet This Rating  Share This Rating on StockTwits
4/22/2014Citigroup Inc.UpgradeSell -> NeutralViewTweet This Rating  Share This Rating on StockTwits
4/21/2014Canaccord GenuityUpgradeHold -> Buy$27.00 -> $63.00ViewTweet This Rating  Share This Rating on StockTwits
4/21/2014JMP SecuritiesUpgradeMarket Perform -> Outperform$54.00ViewTweet This Rating  Share This Rating on StockTwits
4/21/2014Needham & Company LLCReiterated RatingBuy$36.00 -> $52.00ViewTweet This Rating  Share This Rating on StockTwits
4/21/2014William BlairUpgradeMarket Perform -> Outperform$63.00ViewTweet This Rating  Share This Rating on StockTwits
4/14/2014SidotiInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
3/4/2014Canaccord GenuityBoost Price TargetHold$25.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
1/27/2014JMP SecuritiesDowngradeOutperform -> Market Perform$25.00ViewTweet This Rating  Share This Rating on StockTwits
1/24/2014Canaccord GenuityBoost Price Target$20.00 -> $25.00ViewTweet This Rating  Share This Rating on StockTwits
1/21/2014Needham & Company LLCUpgradeHold -> Buy$36.00ViewTweet This Rating  Share This Rating on StockTwits
1/6/2014Citigroup Inc.DowngradeNeutral -> Sell$13.00ViewTweet This Rating  Share This Rating on StockTwits
12/23/2013Piper JaffrayUpgradeUnderweight -> Neutral$19.55 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
12/6/2013Canaccord GenuityDowngradeBuy -> Hold$20.00ViewTweet This Rating  Share This Rating on StockTwits
11/26/2013WBB SecuritiesUpgradeSell -> Speculative Buy$9.00 -> $19.00ViewTweet This Rating  Share This Rating on StockTwits
11/13/2013Canaccord GenuityLower Price TargetBuy$20.00ViewTweet This Rating  Share This Rating on StockTwits
11/12/2013Robert W. BairdLower Price TargetOutperform$63.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
11/12/2013Leerink SwannLower Price TargetMarket Perform$44.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
11/12/2013WedbushLower Price TargetOutperform$60.00 -> $45.00ViewTweet This Rating  Share This Rating on StockTwits
11/12/2013Deutsche BankDowngradeBuy -> Hold$71.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
11/12/2013FBR Capital MarketsLower Price TargetMarket Perform$48.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
11/12/2013Janney Montgomery ScottDowngradeNeutral -> SellViewTweet This Rating  Share This Rating on StockTwits
11/12/2013William BlairDowngradeOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
11/12/2013Needham & Company LLCDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
11/12/2013Piper JaffrayDowngradeOverweight -> Underweight$58.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
10/30/2013FBR & CoInitiated CoverageMarket PerformViewTweet This Rating  Share This Rating on StockTwits
10/30/2013FBR Capital MarketsInitiated CoverageMarket Perform$48.00ViewTweet This Rating  Share This Rating on StockTwits
10/7/2013Deutsche BankReiterated RatingFair Value$213.00ViewTweet This Rating  Share This Rating on StockTwits
10/3/2013Robert W. BairdReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
9/26/2013Canaccord GenuityReiterated RatingPositive -> Buy$65.00ViewTweet This Rating  Share This Rating on StockTwits
9/23/2013Needham & Company LLCReiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
9/20/2013Piper JaffrayUpgradeNeutral -> OverweightViewTweet This Rating  Share This Rating on StockTwits
9/20/2013Deutsche BankUpgradeHold -> Buy$45.00 -> $71.00ViewTweet This Rating  Share This Rating on StockTwits
9/5/2013Stifel NicolausInitiated CoverageBuy$51.00ViewTweet This Rating  Share This Rating on StockTwits
8/27/2013Citigroup Inc.Initiated CoverageNeutralViewTweet This Rating  Share This Rating on StockTwits
7/25/2013JMP SecuritiesBoost Price TargetMarket Outperform$50.00 -> $55.00ViewTweet This Rating  Share This Rating on StockTwits
7/25/2013Canaccord GenuityBoost Price TargetBuy$47.00 -> $65.00ViewTweet This Rating  Share This Rating on StockTwits
7/24/2013Burrill Institutional ResearchDowngradeOutperform -> Market Perform$39.00ViewTweet This Rating  Share This Rating on StockTwits
7/24/2013Deutsche BankDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
7/24/2013Piper JaffrayDowngradeOverweight -> Neutral$44.85 -> $44.48ViewTweet This Rating  Share This Rating on StockTwits
6/26/2013Deutsche BankReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
5/30/2013WedbushReiterated RatingOutperform$60.00ViewTweet This Rating  Share This Rating on StockTwits
5/13/2013Burrill Institutional ResearchReiterated RatingOutperform$39.00ViewTweet This Rating  Share This Rating on StockTwits
5/10/2013Leerink SwannLower Price TargetMarket Perform$41.00 -> $37.00ViewTweet This Rating  Share This Rating on StockTwits
4/22/2013Needham & Company LLCInitiated CoverageBuy$57.00ViewTweet This Rating  Share This Rating on StockTwits
4/16/2013Piper JaffrayBoost Price TargetOverweight$35.00 -> $50.00ViewTweet This Rating  Share This Rating on StockTwits
4/16/2013Janney Montgomery ScottDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
4/16/2013Leerink SwannDowngradeOutperform -> Market Perform$45.00 -> $419.00ViewTweet This Rating  Share This Rating on StockTwits
4/15/2013WedbushReiterated RatingOutperform$60.00ViewTweet This Rating  Share This Rating on StockTwits
4/9/2013Deutsche BankReiterated RatingBuy$45.00ViewTweet This Rating  Share This Rating on StockTwits
4/9/2013Canaccord GenuityInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
4/5/2013Piper JaffrayReiterated RatingOverweight$35.00ViewTweet This Rating  Share This Rating on StockTwits
4/3/2013Robert W. BairdInitiated CoverageOutperform$63.00ViewTweet This Rating  Share This Rating on StockTwits
3/20/2013William BlairInitiated CoverageOutperform$52.00ViewTweet This Rating  Share This Rating on StockTwits
3/19/2013Deutsche BankInitiated CoverageBuy$45.00ViewTweet This Rating  Share This Rating on StockTwits
3/8/2013Burrill Institutional ResearchLower Price TargetOutperform$54.00 -> $39.00ViewTweet This Rating  Share This Rating on StockTwits
3/7/2013Piper JaffrayReiterated RatingOverweight$35.00ViewTweet This Rating  Share This Rating on StockTwits
3/5/2013Leerink SwannInitiated CoverageOutperform$45.00ViewTweet This Rating  Share This Rating on StockTwits
1/25/2013Cowen and CompanyInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
1/2/2013Piper JaffrayLower Price TargetPositive$35.00ViewTweet This Rating  Share This Rating on StockTwits
12/7/2012Piper JaffrayReiterated RatingBuy -> PositiveViewTweet This Rating  Share This Rating on StockTwits
11/27/2012Dominick & DominickInitiated CoverageMarket PerformViewTweet This Rating  Share This Rating on StockTwits
11/27/2012Dawson JamesInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
11/26/2012Burrill Institutional ResearchInitiated CoverageOutperform$54.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/25/2012 forward)
Discuss Sarepta Therapeutics